| 2025 | Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer Progression
| CANCER GENOMICS & PROTEOMICS |
| 2025 | Single-Cell RNA Sequencing Analysis Highlights M2-Like Tumor-Associated Macrophages' Role In Poor Response To Radiotherapy In Cervical Cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2025 | Phosphatidylserine Decarboxylase Overexpression Induced Reprogramming Of Fatty Acid Metabolism Confers And Platinum Based Chemoresistance In P53 Dependent Manner In Epithelial Ovarian Cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2025 | Molecular characterization of ovarian mesonephric-like adenocarcinoma: Insights from single-cell RNA sequencing and mitochondrial metabolism
| GYNECOLOGIC ONCOLOGY REPORTS |
| 2024 | Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2024 | Comparison of Adverse Events Between PARP Inhibitors in Patients with Epithelial Ovarian Cancer: A Nationwide Propensity Score Matched Cohort Study | TARGETED ONCOLOGY |
| 2023 | High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer
| ONCOLOGY REPORTS |
| 2022 | High FKBPL expression contributes to cell proliferation by regulating the cell cycle and affects prognosis in ovarian cancer patients | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HIGH EXPRESSION OF VACUOLAR-ATPASE SUBUNIT ATP6V1B1 PROMOTES POOR PROGNOSIS AND TUMORIGENIC CHARACTERISTICS IN EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HIGH EXPRESSION OF PHOSPHODIESTERASE 1 (PDE1A) PROMOTES POOR PROGNOSIS AND ASSOCIATED WITH PLATINUM BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis
| CANCER GENOMICS & PROTEOMICS |
| 2022 | RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer | JOURNAL OF GENE MEDICINE |
| 2022 | NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE |
| 2022 | Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2021 | CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer
| CANCER GENOMICS & PROTEOMICS |
